Determination of the therapeutic efficacy of ginger in the treatment of migraine headaches
Phase 3
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20220818055740N2
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age between 18 to 65 years; history of migraine headache before performing the study based on IHS criteria; headache from moderate to severe less than six days by visual analogue score(Vas); absence of diseases such as liver, heart, active stomach ulcer, diabetes and renal failure.
Exclusion Criteria
Abnormal vital signs during the study;, new abnormal findings during CT scan; dissatisfaction patients to continue the study;, and observation of drug sensitivity.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Migraine headache. Timepoint: One month after intervention. Method of measurement: VAS, PSQI, MIDAS questionnaires.
- Secondary Outcome Measures
Name Time Method Migraine headache. Timepoint: One month after intervention. Method of measurement: VAS, PSQI, MIDAS questionnaires.